Carsten Lukas

Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

Alexander Duscha, Barbara Gisevius, Sarah Hirschberg et al. · Cell · 2020 · 580 citations · Full text

Inflammation, Autoimmune Disease, Medicine +11

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open‐label, baseline‐controlled pilot study

Sebastian Schimrigk, N. Brune, Kerstin Hellwig et al. · European Journal of Neurology · 2006 · 211 citations

Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model

Martin Stangel, Iris‐Katharina Penner, Boris Kallmann et al. · Therapeutic Advances in Neurological Disorders · 2014 · 158 citations · Full text

Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla

Birgit Simon, Stephan Schmidt, Carsten Lukas et al. · European Radiology · 2010 · 152 citations · Full text

Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients

Carsten Lukas, Madeleine H Sombekke, Barbara Bellenberg et al. · Radiology · 2013 · 145 citations